Clinical Trials and Research
- 07.0240 - A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients with Stage II and III Ovarian Carcinoma. learn more
- 05.0451 - Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer learn more
- 06.0364 - A Phase III, Randomized Trial of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical Carcinoma Limited to the Pelvis learn more
- 06.0364 - A Phase III, Randomized Trial of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis learn more
- 07.0327 - A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied agent, NSC#683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma learn more
- 05.0374 - University of Louisville Registry for Patients Treated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy learn more
- 05.0376 - University of Louisville Registry for Patients with Gynecologic Malignancy Treated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (Prospective) learn more
- 06.0290 - A Single-Arm, Open-Label, Phase II Study to Assess the Safety and Efficacy of the Trifunctional Antibody Catumaxomab Administered Intraperitoneally in Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites learn more
- 01.0328 - The University of Louisville Ovarian Screening Study learn more
- 06.0182 - A Molecular Staging Study of Endometrial Carcinoma learn more
- 06.0102 - Phase II Trial of Radiation Therapy and Weekly Cisplatin Chemotherapy for the Treatment of Locally-advanced Squamous Cell Carcinoma of the Vulva learn more
- 06.0085 - Phase III Trial of Carboplatin and Paclitaxel plus placebo vs. Carboplatin and Paclitaxel plus concurrent Bevacizumab followed by placebo, versus Carboplatin and Paclitaxel plus concurrent and extended Bevacizumab in women with newly diagnosed, previously untreated, suboptimal advanced stage epithelial ovarian and primary peritoneal cancer learn more
- 05.0451 - A Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent, Endometrial Cancer learn more
|